SciSparc Ltd. Announces Pricing of $5.026 Million Private Placement
TEL AVIV, ISRAEL, Oct. 11, 2023 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (“SciSparc” or…
TEL AVIV, ISRAEL, Oct. 11, 2023 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (“SciSparc” or…
Singapore, Oct 11, 2023 – (ACN Newswire) – Artificial intelligence (AI) has experienced a breakout…
Driving customer value through innovation SANTA CLARA, Calif.–(BUSINESS WIRE)–Arista Networks (NYSE:ANET) today announced the next…
Acxiom enables joint customers to build leading solutions on Snowflake’s Data Cloud that unlocks valuable…
C3 AI Reliability to include the AI models and specific features developed by Shell Global…
RapidSOS will integrate seamlessly into CentralSquare’s Computer Aided Dispatch (CAD) to introduce multimedia services, including…
Live moderated webcast with J.D. Finley, Chief Executive Officer of Palisade Bio on Wednesday, October…
Live moderated webcast with J.D. Finley, Chief Executive Officer of Palisade Bio on Wednesday, October…
– Live moderated webcast with Marc Hertz, Chief Executive Officer of GRI Bio on Tuesday,…
– Live moderated webcast with Marc Hertz, Chief Executive Officer of GRI Bio on Tuesday,…
Studies address cost-effectiveness and budget impact of INPEFA, an inhibitor of SGLT2 and SGLT1 INPEFA recently…
Studies address cost-effectiveness and budget impact of INPEFA, an inhibitor of SGLT2 and SGLT1 INPEFA recently…
TORONTO, Oct. 11, 2023 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB:…
TORONTO, Oct. 11, 2023 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB:…
-On track for commercial launch of first herbicide tolerant Camelina variety as early as 2025…
-On track for commercial launch of first herbicide tolerant Camelina variety as early as 2025…
TORONTO and HAIFA, Israel, Oct. 11, 2023 (GLOBE NEWSWIRE) — NurExone Biologic Inc. (TSXV: NRX)…
TORONTO and HAIFA, Israel, Oct. 11, 2023 (GLOBE NEWSWIRE) — NurExone Biologic Inc. (TSXV: NRX)…
Collaboration underscores Conduit’s mission to advance promising treatments by developing assets that have already completed…
Collaboration underscores Conduit’s mission to advance promising treatments by developing assets that have already completed…